FR24C1023I1
(en )
2024-07-26
THERAPEUTIC ANTIBODIES AND THEIR USES
MA49537A
(en )
2020-05-13
ANTI-LAG3 ANTIBODIES AND THEIR USES
MA46708A
(en )
2021-05-05
ANTI-PD1 ANTIBODIES AND THEIR USES
MA47789A
(en )
2020-01-22
ANTI-PHF-TAU ANTIBODIES AND THEIR USES
MA45235A
(en )
2019-04-17
ANTI-C5 ANTIBODIES AND THEIR USES
MA49683A
(en )
2020-06-03
ANTI-CD8 ANTIBODIES AND THEIR USES
MA45125A
(en )
2021-06-02
ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND THEIR USES
MA49687A
(en )
2020-06-03
ANTI-CTLA-4 ANTIBODIES AND THEIR USES
MA53184A
(en )
2021-05-26
ANTI-OX40 ANTIBODIES AND THEIR USES
MA50618A
(en )
2020-08-12
POLYRHERAPIES AND THEIR USES
MA49886A
(en )
2020-06-24
ANTI-PAR2 ANTIBODIES AND THEIR USES
MA50144A
(en )
2020-07-29
ANTI-PEPTID BETA-AMYLOID ANTIBODIES N3PGLU AND ASSOCIATED USES
MA52773A
(en )
2021-04-14
ANTI-CD3 ANTIBODIES AND THEIR USES
MA42935A
(en )
2018-08-01
OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND THEIR USES
MA50397A
(en )
2020-08-26
ANTI-BODY ANTI-TAU AND THEIR USES
MA46704A
(en )
2019-09-11
ANTI-PYROGLUTAMATE- AMYLOID-BETA ANTIBODIES AND THEIR USES
MA46525A
(en )
2019-08-21
ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS
MA47694A
(en )
2021-05-19
ANTI-TIGIT ANTIBODY
MA45233A
(en )
2019-04-17
ANTI-GITR ANTIBODIES AND THEIR USES
MA46471A
(en )
2021-05-19
ACTRIIB VARIANT PROTEINS AND THEIR USES
MA52949A
(en )
2021-04-28
ANTI-PD-1 ANTIBODIES AND THEIR USES
MA44659A
(en )
2021-04-14
ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS
MA43567A
(en )
2018-11-14
PACAP ANTIBODIES AND THEIR USES
MA47268A
(en )
2019-11-20
ANTIBODY ANTI-GPC3
MA53400A
(en )
2021-08-04
ALK7 HETEROMULTIMERS: ACTRIIB AND THEIR USES